Asia Insurance Post
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
Select Page

Apple iPhones get bigger and pricier, Watch turns to health

by AIP Online Bureau | Sep 16, 2020 | Eco/Invest/Demography, Facts, Health, Technology

  CUPERTINO, Calif: Apple Inc introduced its largest-ever iPhone and a watch that detects heart problems on Wednesday in an attempt to get customers to upgrade to more expensive devices in the face of stagnant global demand for smartphones.The relatively small...

Global net zero emissions goal would require $1-2 trillion a year investment: study

by AIP Online Bureau | Sep 16, 2020 | Climate, Environment, Renewable Energy, Eco/Invest/Demography, International News

  LONDON: Achieving net zero emissions by mid-century would cost an estimated $1 trillion-$2 trillion a year of additional investments, or 1-1.5% of global gross domestic product, a report by the Energy Transitions Commission (ETC) said on Wednesday.To limit...

Some Indian hospitals scramble for oxygen as coronavirus cases top 5 million

by AIP Online Bureau | Sep 16, 2020 | Eco/Invest/Demography, Health, Indian News, Non-Life, Pandemic

  MUMBAI: India’s coronavirus infections surged past 5 million on Wednesday, piling pressure on hospitals grappling with unreliable supplies of oxygen that they need to treat tens of thousands of critical patients.In the big states of Maharashtra, Gujarat...

RBI chief says India’s recovery not entrenched, will only be gradual

by AIP Online Bureau | Sep 16, 2020 | Eco/Invest/Demography, Indian News, Pandemic, Risk Management

  MUMBAI: Some high frequency indicators are pointing towards stabilisation in economic activity in India but the recovery is still not entrenched and will only be gradual, Reserve Bank of India Governor Shaktikanta Das said on Wednesday.The major economy hardest...

Serum Institute gets approval to resume India trial of AstraZeneca COVID vaccine: source

by AIP Online Bureau | Sep 16, 2020 | Eco/Invest/Demography, Health, Indian News, Pandemic

MUMBAI/NEW DELHI: Serum Institute of India has received Indian regulatory approval to resume local clinical trials of AstraZeneca’s potential COVID-19 vaccine, a source familiar with the matter said on Wednesday. The approval came from the Drugs Controller...
« Older Entries
Next Entries »

Recent Posts

  • Air Canada Express plane hits ground vehicle at New York’s LaGuardia airport,multiple injuries reported
  • Women & Financial Independence:Navigating insurance and long term planning
  • Building Risk Resilience: An update for India Inc
  • Musk found liable to Twitter shareholders in fraud lawsuit over $44 billion takeover
  • Govt may consider OFS option for raising public float in IDBI Bank

Categories

  • Articles
  • Banking & Bancassurance
  • Blog
  • Breaking News!
  • Briefs
  • Climate, Environment, Renewable Energy
  • Data
  • Disaster & Management
  • Eco/Invest/Demography
  • Editorial
  • Events
  • Facts
  • Features
  • Health
  • Indian News
  • Intermediaries
  • International News
  • Interviews
  • Life
  • Main Menu
  • Non-Life
  • Pandemic
  • Pension & Social Security
  • Policy
  • Regulation
  • Reinsurance
  • Risk Management
  • Simple
  • Technology
  • Trends, Facts
  • Uncategorized
  • Wealth Management/ Philanthropy
  • Workplace/Employee Benefits
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
  • Eco/Invest/Demography
  • Indian News
  • International News
  • Health
  • Non-Life
  • Pandemic
  • Technology
  • Risk Management
  • Reinsurance
  • Banking & Bancassurance
  • Wealth Management/ Philanthropy